Stay updated on LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.

Latest updates to the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoChange DetectedThe webpage has updated its date references, adding new dates in April 2025 while removing older dates from February 2025.SummaryDifference0.5%
- Check23 days agoChange DetectedThe page has been updated to include new drug information, specifically the addition of Alpelisib and Pertuzumab, while significant details about the previous study involving LY3484356 have been removed.SummaryDifference17%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 28, 2025.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 28, 2025, and version 2.14.2.SummaryDifference0.2%
- Check66 days agoChange DetectedThe webpage has updated its date references to include February 2025 while removing older dates from January 2025. Additionally, a notice regarding service performance and contact information for assistance has been removed.SummaryDifference2%
Stay in the know with updates to LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.